Ropinirole increases open field distance travelled in sham-lesioned rats
Animal study · Adult female Sprague-Dawley rats; sham lesions; nsham = 9 [1]
Treatment with ropinirole induced a large increase in distance travelled in both sham-lesioned and 6-OHDA-lesioned rats. During the EPM test, ropinirole did not induce an increase in the total distance travelled as seen in the open field test, but instead reduced the distance travelled compared with both L-DOPA and vehicle treatment.
| Endpoint | Reported result | Reference |
|---|---|---|
| distance travelled | distance travelled >20-fold increase | [1] |
Conditions shared by the study groups
- Route
- s.c. injections
- Treatment course
- daily; five consecutive days (day 1 to day 5) with a drug-free period of two days (days 6 and 7) for a total of 6 weeks; open field test during treatment week 2; 15 min before the beginning of each behavioural test
- Vehicle
- physiological saline solution
| Group / dose | Comparator | Observed result | Reference |
|---|---|---|---|
| Ropinirole 2.5 mg/kg | saline and LD24 | ropinirole 2.5 mg/kg (R2.5); sham-lesioned rats; open field test during treatment week 2: >20-fold increase vs saline and LD24, p < 0.05 | [1] |
- Ropinirole 2.5 mg/kg
- Model: Adult female Sprague-Dawley rats; sham lesions; nsham = 9
Methods and source locations
Compound reported in the paper: Ropinirole
The paper names Ropinirole without stating the salt or form; not verified as the hydrochloride form supplied as A11916. No dose conversion or lot validation.
Results > Evaluation of the 6-OHDA lesion and motor effects of the treatments (S6); Results > Ropinirole, but not L-DOPA, induced hyperactivity with signs of reduced anxiety (S22); Methods > Animals (S136); Methods > Study design (S138, S139, S141); Methods > Drug treatments (S146, S149); Methods > Bilateral dopamine-denervating lesions (S158)
distance travelled: distance travelled; comparator: saline and LD24 — Results > Ropinirole, but not L-DOPA, induced hyperactivity with signs of reduced anxiety (S22); Methods > Study design (S138, S141)
Ropinirole 2.5 mg/kg · Results > Ropinirole, but not L-DOPA, induced hyperactivity with signs of reduced anxiety (S22); Methods > Study design (S138, S139, S141); Methods > Drug treatments (S149)